69.89
3.14%
2.13
시간 외 거래:
69.89
Edwards Lifesciences Corp (EW) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
4.18%
1,598.20
|
1,534.10 | 1,480.90 | 1,530.20 | 1,459.60 |
Cost Of Revenue |
8.04%
385.60
|
356.90 | 350.40 | 343.00 | 329.50 |
Gross Profit |
3.01%
1,212.60
|
1,177.20 | 1,130.50 | 1,187.20 | 1,130.10 |
Operating Expenses
|
6.18%
825.10
|
777.10 | 712.10 | 860.00 | 741.70 |
Benefits Costs and Expenses |
6.87%
1,188.80
|
1,112.40 | 1,041.60 | 1,191.70 | 1,061.00 |
Costs And Expenses |
6.87%
1,188.80
|
1,112.40 | 1,041.60 | 1,191.70 | 1,061.00 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
3.15%
387.50
|
400.10 | 418.40 | 327.20 | 388.40 |
Net Interest Income/Expense |
16.50
|
- | 15.10 | 9.10 | 8.60 |
Interest Income/Expense After Provision For Losses |
16.50
|
- | 15.10 | 9.10 | 8.60 |
Income/Loss From Continuing Operations Before Tax |
2.92%
409.40
|
421.70 | 439.30 | 338.50 | 398.60 |
Income Tax Expense/Benefit |
12.31%
58.40
|
52.00 | 55.60 | 33.00 | 58.10 |
Income/Loss From Continuing Operations After Tax |
5.06%
351.00
|
369.70 | 383.70 | 305.50 | 340.50 |
Net Income/Loss
|
5.06%
351.00
|
369.70 | 383.70 | 305.50 | 340.50 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
350.00%
-0.90
|
-0.20 | -1.20 | -1.60 | - |
Basic Average Shares |
120.42K%
601.60
|
-0.50 | 607.00 | 606.90 | 607.50 |
Diluted Average Shares |
75,612%
604.10
|
-0.80 | 609.50 | 610.30 | 610.90 |
Basic Earnings Per Share |
4.92%
0.58
|
0.61 | 0.63 | 0.51 | 0.56 |
Diluted Earnings Per Share |
4.92%
0.58
|
0.61 | 0.63 | 0.50 | 0.56 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):